Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Autoimmune thyroid disease (AITD) is often observed together with other autoimmune diseases. The coexistence of two or more autoimmune diseases in the same patient is referred to as polyautoimmunity, and AITD is the autoimmune disease most frequently involved. The occurrence of polyautoimmunity has led to the hypothesis that the affected patients suffer from a generalized dysregulation of their immune system. The present review summarizes recent discoveries unravelling the immunological mechanisms involved in autoimmunity, ranging from natural autoimmunity to disease-specific autoimmunity. Furthermore, the clinical grounds for considering AITD in a setting of polyautoimmunity are explored. A better understanding of these may pave the way for designing new treatment modalities targeting the underlying immune dysregulation when AITD appears in the context of polyautoimmunity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
The epidemiology of thyroid disease
Vanderpump, M. P. J. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr030 · Cited by 1,179
Rituximab, B-lymphocyte depletion, and preservation of beta-cell function
Pescovitz, M. D., Greenbaum, C. J., Krause-Steinrauf, H., Becker, D. J., Gitelman, S. E., Goland, R., Gottlieb, P. A., Marks, J. B., McGee, P. F., Moran, A. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904452 · Cited by 1,093 · cited 1×
“Incorporation of rituximab, a B cell–depleting agent, has shown promising results in patients with GO 102–104 in addition to amel-iorating numerous other autoimmune diseases, such as rheumatoid arthritis 103,105 , multiple sclerosis 106 , and type 1 diabetes 107 .”
BackgroundManagement of toxicities of immune checkpoint inhibitors
Spain, L., Diem, S., & Larkin, J. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.02.001 · Cited by 854
Thangaratinam, S., Tan, A., Knox, E., Kilby, M. D., Franklyn, J., & Coomarasamy, A. (2011) · BMJ · doi:10.1136/bmj.d2616 · Cited by 604 · cited 1×
“In studies of reproductive failure, especially autoantibodies involved in the anti-phospholipid syndrome (that is, anti-cardiolipin antibodies) 82 but also thyroid autoantibodies 83,84 have been associated with worsened pregnancy outcomes.”
BackgroundCHRONIC THYROIDITIS AND AUTOIMMUNIZATION
Witebsky, E. (1957) · Journal of the American Medical Association · doi:10.1001/jama.1957.02980130015004 · Cited by 547 · cited 1×
“In the 1950s, it was recognized that certain “shared threads” characterized autoimmune diseases 56,57 , a notion which has since been the subject of much debate and research.”
BackgroundBoelaert, K., Newby, P. R., Simmonds, M. J., Holder, R. L., Carr-Smith, J. D., Heward, J. M., Manji, N., Allahabadia, A., Armitage, M., Chatterjee, K. V., et al. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.06.030 · Cited by 480
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis
Coles, A. J., Wing, M., Smith, S., Coraddu, F., Greer, S., Taylor, C., Weetman, A., Hale, G., Chatterjee, V. K., Waldmann, H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02429-0 · Cited by 453
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437 · cited 2×
“Before combination therapy with thyroxine and triiodothyronine is considered, a search for other autoimmune diseases in a patient with AITD and poor PROs is now mandatory 93 .”
BackgroundEndocrine Side Effects Induced by Immune Checkpoint Inhibitors
Corsello, S. M., Barnabei, A., Marchetti, P., De Vecchis, L., Salvatori, R., & Torino, F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4075 · Cited by 403 · cited 1×
“More rarely, autoimmune primary thyroid affection or adrenal insufficiency occurs 99 .”
Background
Cited by
Bliddal, S., Feldt-Rasmussen, U., Rasmussen, Å. K., Kolte, A. M., Hilsted, L. M., Christiansen, O. B., Nielsen, C. H., & Nielsen, H. S. (2019) · Thyroid® · doi:10.1089/thy.2019.0077 · Cited by 63
Self-citationLevothyroxine therapy in elderly patients with hypothyroidism
Effraimidis, G., Watt, T., & Feldt-Rasmussen, U. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.641560 · Cited by 60
“Some of these challenges can be overcome by getting a good overview of the patient’s concomitant diseases, or eventually look for other likely candidates as explanation for the patient’s complaints such as presence of other autoimmune diseases, particularly those that might compromise T4 absorption such as pernicious…”
BackgroundSelf-citationLevothyroxine therapy in gastric malabsorptive disorders
Virili, C., Brusca, N., Capriello, S., & Centanni, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.621616 · Cited by 52
“of the balance between pro- and anti-inflammatory effector cells pathways (52, 53).”
BackgroundSkov, J., Calissendorff, J., Eriksson, D., Magnusson, P., Kämpe, O., Bensing, S., & Kuja-Halkola, R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa956 · Cited by 25
“manifestations on an autoimmune continuum rather than etiologically distinct entities, has also been suggested (23).”
Background
Metadata
- Authors
- Bliddal, S., Nielsen, C. H., & Feldt-Rasmussen, U.
- Venue
- F1000Research
- Publisher
- F1000 Research Ltd
- Published
- 2017-09-28
- Volume
- 6
- Pages
- 1776
- ISSN
- 2046-1402 (ISSN-L)
- OpenAlex
- W2757857396
- Cited by
- 133
- References
- 15
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. https://app.cochat.ai/papers/10.12688/f1000research.11535.1
- The paper
- Bliddal, S., Nielsen, C. H., & Feldt-Rasmussen, U. (2017). Recent advances in understanding autoimmune thyroid disease: the tallest tree in the forest of polyautoimmunity. F1000Research. https://doi.org/10.12688/f1000research.11535.1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.